Antagonists of the Mineralocorticoid Receptor or A New Pharmacological Class?

Milla Marques Hermidorff¹, Leonardo Vinícius Monteiro De Assis² and Mauro César Isoldi^1*

¹Research Center in Biological Sciences, Department of Biological Sciences, Federal University of Ouro Preto (UFOP), Ouro Preto, Minas Gerais, Brazil

²Department of Physiology, Institute of Biosciences, University of São Paulo (USP), São Paulo, Brazil

^*Corresponding Author: Mauro César Isoldi, Research Center in Biological Sciences, Department of Biological Science and Technology, Federal University of Ouro Preto (UFOP), Ouro Preto, Minas Gerais, Brazil Email:

Opinion